METASTATIC BILIARY TRACT CARCINOMA
Clinical trials for METASTATIC BILIARY TRACT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BILIARY TRACT CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC BILIARY TRACT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a targeted antibody boost chemotherapy for a rare bile duct cancer?
Disease control Not yet recruitingThis phase 2 trial is testing whether adding zolbetuximab, an antibody that targets a protein called claudin 18.2, to standard chemotherapy can help control advanced or metastatic biliary tract cancers. The study enrolls adults whose tumors overexpress this protein. Participants …
Matched conditions: METASTATIC BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: Midhun Malla • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New drug cocktail targets cancers missing key gene
Disease control Not yet recruitingThis study tests a new drug combination for people with metastatic solid tumors that lack a gene called MTAP. The drugs, BMS-986504 and pemetrexed, aim to stop cancer cells from growing. The trial will check safety and how well the combo works in 72 participants.
Matched conditions: METASTATIC BILIARY TRACT CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC